131 related articles for article (PubMed ID: 38294744)
1. Clinical Efficacy and Safety of Liraglutide and Dapagliflozin on Glucose and Lipid Metabolism and Insulin Function in Patients with Type 2 Diabetes Mellitus.
Ma J; Fu J; Guo N; Liu Z
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38294744
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China.
Zhaohu H; Xiao H; Hailin S; Feng H
J Diabetes Res; 2022; 2022():4126995. PubMed ID: 35990242
[TBL] [Abstract][Full Text] [Related]
3. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
Li JY; Wu GM; Hou Z; Cao YM
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy and safety of human glucagon-like peptide-1 analogue liraglutide in newly diagnosed type 2 diabetes with glycosylated hemoglobin A1c > 9].
Yan L; Wang S; Chen P; Chen C; Shao Z; Xu X; Huang Q
Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):307-12. PubMed ID: 26268058
[TBL] [Abstract][Full Text] [Related]
5. [Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes: efficacy, weight control and safety].
Xu Y; Wu P; Wen W; Chen H
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1305-1311. PubMed ID: 31852646
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Clinical Efficacy of the Treatment of Overweight and Obesity in Type 2 Diabetes Mellitus by the Telemedicine Management System Based on the Internet of Things Technology.
Lin K; Zhang W; He F; Shen J
Comput Intell Neurosci; 2022; 2022():8149515. PubMed ID: 35785080
[TBL] [Abstract][Full Text] [Related]
7. [The effect of liraglutide in combination with human umbilical cord mesenchymal stem cells treatment on glucose metabolism and β cell function in type 2 diabetes mellitus].
Chen P; Huang Q; Xu XJ; Shao ZL; Huang LH; Yang XZ; Guo W; Li CM; Chen C
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):349-54. PubMed ID: 27143183
[TBL] [Abstract][Full Text] [Related]
8. Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients.
Zhou X; Luo M; Zhou S; Cheng Z; Chen Z; Yu X
Diabetes Metab Syndr Obes; 2021; 14():379-385. PubMed ID: 33536771
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Dapaglifozin and Liraglutide in Patients with Poorly Controlled Type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial.
Jiang J; Lin L; Chen P
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1366-1374. PubMed ID: 32875989
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
Guo W; Tian W; Lin L; Xu X
Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
[TBL] [Abstract][Full Text] [Related]
12. [BO's abdominal acupuncture for obese type-2 diabetes mellitus].
Yang Y; Liu Y
Zhongguo Zhen Jiu; 2015 Apr; 35(4):330-4. PubMed ID: 26054139
[TBL] [Abstract][Full Text] [Related]
13. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Homocysteine, AHSG, CRP with Insulin Resistance, 25-(OH)2-VitD, Blood Lipids in Gestational Diabetes Patients.
Jiang XC; Liang ZD; Chen DL; Jia JP; Hu JR; Hu L
Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616345
[TBL] [Abstract][Full Text] [Related]
15. [Relations between serum adipocyte fatty acid-binding protein and type 2 diabetes in a community population].
YE WH; PENG XH; AI YQ; CHEN H; ZHANG H; CAI DH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):508-11. PubMed ID: 21421494
[TBL] [Abstract][Full Text] [Related]
16. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
Zhang Z; Wang J; Wang H
Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698
[TBL] [Abstract][Full Text] [Related]
17. The effects of GLP-1 analogues on pre-diabetes of the children.
Zhou QX; Wang ZY; Zhao HF; Wang S
Exp Ther Med; 2017 Apr; 13(4):1426-1430. PubMed ID: 28413488
[TBL] [Abstract][Full Text] [Related]
18. Investigating the changes in the levels of HbA1c, blood fat and insulin sensitivity in elder patients with type II diabetes mellitus due to combined medication of pioglitazone and melbine and single-use of pioglitazone.
Sun Y; Yu Q; Xie J
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):21-28. PubMed ID: 33040780
[TBL] [Abstract][Full Text] [Related]
19. Analysis on difference in gastrointestinal hormone levels of patients with the history of diabetes and concurrent nephropathy and study on the role of liraglutide.
Zhang JH; Liu XR; Sheng CX; Liu YE
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3523-3529. PubMed ID: 28829486
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice.
Millar P; Pathak N; Parthsarathy V; Bjourson AJ; O'Kane M; Pathak V; Moffett RC; Flatt PR; Gault VA
J Endocrinol; 2017 Sep; 234(3):255-267. PubMed ID: 28611211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
